Long-term ozone exposure and mortality from neurological diseases in Canada

被引:39
|
作者
Zhao, Naizhuo [1 ]
Pinault, Lauren [2 ]
Toyib, Olaniyan [2 ]
Vanos, Jennifer [3 ]
Tjepkema, Michael [2 ]
Cakmak, Sabit [4 ]
机构
[1] McGill Univ, Div Clin Epidemiol, Hlth Ctr, Montreal, PQ, Canada
[2] Stat Canada, Hlth Stataist Div, Ottawa, ON, Canada
[3] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA
[4] Hlth Canada, Populat Studies Div, Environm Hlth Sci & Res Bur, 101 Tunneys Pasture Driveway, Ottawa, ON K1A 0K9, Canada
关键词
Ozone exposure; Parkinson's; Dementia; Stroke; Multiple sclerosis; Mortality; ENVIRONMENT COHORT CANCHEC; AMBIENT AIR-POLLUTION; CENSUS HEALTH; GLOBAL BURDEN; PM2.5; RISK; ASSOCIATIONS; DEMENTIA; SYSTEM; NO2;
D O I
10.1016/j.envint.2021.106817
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: There is increasing interest in the health effects of air pollution. However, the relationships between ozone exposure and mortality attributable to neurological diseases remain unclear. Objectives: To assess associations of long-term exposure to ozone with death from Parkinson's disease, dementia, stroke, and multiple sclerosis. Methods: Our analyses were based on the 2001 Canadian Census Health and Environment Cohort. Census participants were linked with vital statistics records through 2016, resulting in a cohort of 3.5 million adults/ 51,045,700 person-years, with 8,500/51,300/43,300/1,300 deaths from Parkinson's/dementia/stroke/multiple sclerosis, respectively. Ten-year average ozone concentrations estimated by chemical transport models and adjusted by ground measurements were assigned to subjects based on postal codes. Cox proportional hazards models were used to calculate hazard ratios (HRs) for deaths from the four neurological diseases, adjusting for eight common demographic and socioeconomic factors, seven environmental indexes, and six contextual covariates. Results: The fully adjusted HRs for Parkinson's, dementia, stroke, and multiple sclerosis mortalities related to one interquartile range increase in ozone (10.1 ppb), were 1.09 (95% confidence interval 1.04-1.14), 1.08 (1.06-1.10), 1.06 (1.04-1.09), and 1.35 (1.20-1.51), respectively. The covariates did not influence significance of the ozone-mortality associations, except airshed (i.e., broad region of Canada). During the period of 2001-2016, 5.66%/5.01%/ 3.77%/19.11% of deaths from Parkinson's/dementia/stroke/multiple sclerosis, respectively, were attributable to ozone exposure. Conclusions: We found positive associations between ozone exposure and mortality due to Parkinson's, dementia, stroke, and multiple sclerosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Long-term ozone exposure and ozone uptake of grapevines in open-top chambers
    Soja, G
    Reichenauer, TG
    Eid, M
    Soja, AM
    Schaber, R
    Gangl, H
    ATMOSPHERIC ENVIRONMENT, 2004, 38 (15) : 2313 - 2321
  • [32] Cancer Mortality Risks from Long-term Exposure to Ambient Fine Particle
    Wong, Chit Ming
    Tsang, Hilda
    Lai, Hak Kan
    Thomas, G. Neil
    Lam, Kin Bong
    Chan, King Pan
    Zheng, Qishi
    Ayres, Jon G.
    Lee, Siu Yin
    Lam, Tai Hing
    Thuan Quoc Thach
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (05) : 839 - 845
  • [33] Long-term fluoride exposure from drinking water and chronic diseases.
    Li, Y
    Liang, C
    Ji, R
    Zhang, W
    Niu, S
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A376 - A376
  • [34] Long-term ozone exposure and all-cause mortality: Cohort evidence in China and global heterogeneity by region
    Peng, Minjin
    Zhang, Faxue
    Yuan, Yang
    Yang, Zhiming
    Wang, Kai
    Wang, Yaqi
    Tang, Ziqing
    Zhang, Yunquan
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 270
  • [35] Association of Long-Term Exposure to Particulate Matter and Ozone With Health Status and Mortality in Patients After Myocardial Infarction
    Malik, Ali O.
    Jones, Philip G.
    Chan, Paul S.
    Peri-Okonny, Poghni A.
    Hejjaji, Vittal
    Spertus, John A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2019, 12 (04):
  • [36] Updated Global Estimates of Respiratory Mortality in Adults ≥30 Years of Age Attributable to Long-Term Ozone Exposure
    Malley, Christopher S.
    Henze, Daven K.
    Kuylenstierna, Johan C., I
    Vallack, Harry W.
    Davila, Yanko
    Anenberg, Susan C.
    Turner, Michelle C.
    Ashmore, Mike R.
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2017, 125 (08)
  • [37] LYMPHOCYTE CHANGES AFTER LONG-TERM THERAPY OF SOME NEUROLOGICAL DISEASES
    ENAKE, T
    HRISTOVSKI, D
    MICU, D
    REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1978, 16 (03): : 281 - &
  • [38] Long-term Exposure to Nitrogen Dioxide and Ozone and Respiratory Health in Children
    Zetlen, H. L.
    Rifas-Shiman, S. L.
    Luttmann-Gibson, H.
    Oken, E.
    Gold, D. R.
    Rice, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [39] NEUROLOGICAL DISTURBANCES FOLLOWING LONG-TERM EXPOSURE TO ORGANIC-SOLVENTS
    FOSSAN, GO
    ACTA NEUROLOGICA SCANDINAVICA, 1985, 72 (06): : 606 - 607
  • [40] Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers
    Paulin, Laura M.
    Gassett, Amanda J.
    Alexis, Neil E.
    Kirwa, Kipruto
    Kanner, Richard E.
    Peters, Stephen
    Krishnan, Jerry A.
    Paine, Robert, III
    Dransfield, Mark
    Woodruff, Prescott G.
    Cooper, Christopher B.
    Barr, R. Graham
    Comellas, Alejandro P.
    Pirozzi, Cheryl S.
    Han, MeiLan
    Hoffman, Eric A.
    Martinez, Fernando J.
    Woo, Han
    Peng, Roger D.
    Fawzy, Ashraf
    Putcha, Nirupama
    Breysse, Patrick N.
    Kaufman, Joel D.
    Hansel, Nadia N.
    Anderson, Wayne H.
    Arjomandi, Mehrdad
    Barjaktarevic, Igor
    Bateman, Lori A.
    Bhatt, Surya P.
    Bleecker, Eugene R.
    Boucher, Richard C.
    Bowler, Russell P.
    Christenson, Stephanie A.
    Couper, David J.
    Criner, Gerard J.
    Crystal, Ronald G.
    Curtis, Jeffrey L.
    Doerschuk, Claire M.
    Dransfield, Mark T.
    Drummond, Brad
    Freeman, Christine M.
    Galban, Craig
    Han, Maar K.
    Hastie, Annette T.
    Huang, Yvonne
    Kaner, Robert J.
    Kleerup, Eric C.
    LaVange, Lisa M.
    Lazarus, Stephen C.
    Meyers, Deborah A.
    JAMA INTERNAL MEDICINE, 2020, 180 (01) : 106 - 115